Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 2, 1999, Pages 140-147

  Volk, A ^a   Renn, W ^a   Overkamp, D ^a   Mehnert, B ^a   Maerker, E ^a   Jacob, S ^a   Balletshofer, B ^a   Haring H U ^a   Rett, K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

First degree relatives; Hyperinsulinemia; Insulin resistance; Insulin secretion; Obesity

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RELATIVE;

EID: 0032899013     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212089     Document Type: Article

References (36)

1. Arner P, Pollare T, Lithell H: Different aetiologies of type 2 diabetes mellitus in obese and non-obese subjects. Diabetologia 34: 483-487, 1991
2. Beck-Nielsen H, Henriksen JE, Alford F, Hother-Nielson O: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus and their first degree relatives. Diabetic medicine 13: S78-S84, 1996
3. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223, 1979
4. DeFronzo RA: The Triumvirate: β-cell, Muscle, Liver. Diabetes 37: 667-687, 1988
5. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-326, 1992
6. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews 5: 177-269, 1997
7. Eriksson J, Fransilla-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337-43, 1989
8. Eriksson J, Ekstrand A, Fransilla-Kallunki A, Saloranta C, Widen E, Schalin C, Groop E: Hyperglycemia compensates for impaired glucose disposal in first-degree relatives of NIDDM patients with normal glucose tolerance (Abstract). Acta Endocrinol 120: 11, 1989
9. Eriksson KF, Lindgärde F: Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 39: 573-579, 1996
10. Fernandez-Castaner M, Biarnes J, Camps I, Ripolles J, Gomez N, Soler J: Beta-cell dysfunction in first degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabetic Medicine 13: 953-959, 1996
11. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. J Clin Invest 100: 1166-1173, 1997
12. Gerich J, Van Haeften T: Insulin resistance versus impaired insulin secretion as the genetic basis for type 2 diabetes. Current Opinion in Endocrinology and Diabetes 5: 144-148, 1998
13. Groop LC, Widen E, Ferrannini E: Insulin resistance and insulin deficiency in the pathogenesis of type 2 diabetes mellitus: errors of metabolism or of methods? Diabetologia 36: 1326-1331, 1993
14. Groop L, Forsblom C, Lehtovirta M: Characterization of the prediabetic state. AJH 10: 172-180, 1997
15. Haeften TW, Zonderland MI, Dubbeldam S, Erkelens DW: Insulin secretion in normal glucose tolerant relatives of type 2 diabetic subjects. Diabetes Care 21: 278-282, 1998
16. Henriksen JE, Alford F, Handberg A, Vaag A, Ward GM, Kalfas A, Beck-Nielsen H: Increased glucose effectiveness in normoglycaemic but insulin resistant relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94: 1196-1204, 1994
17. Humphriss DB, Stewart MW, Berrish TS, Barriocanal EA, Trajano LR, Ashworth LA, Brown MD, Miller M, Avery PJ, Alberti KGMM, Walker M: Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia 40: 1185-1190, 1997
18. Ishikawa M, Pruneda ME, Adams-Huet B, Raskin P: Obesity-independent hyperinsulinaemia in nondiabetic first degree relatives of individuals with type 2 diabetes. Diabetes 47: 788-792, 1998
19. Lillioja S, Mott DM, Zawadzki K, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is familial characteristic in nondiabetic pima indians. Diabetes 36: 1329-35, 1987
20. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329: 1988-1992, 1993
21. Migdalis IN, Zachariadis D, Kalogeropoulou K, Nounopoulos C, Bouloukos A, Samartzis: Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus. Diabetic Medicine 13: 434-440, 1996
22. Nagi DK, Knowler WC, Charles MA: Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance. Diabetologia 38: 187-192, 1995
23. Nyholm B, Mengel A, Nielsen S, Skjaerbaek Ch, Moller N, Alberti KGMM, Schmitz O: Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia 39: 813-822, 1996
24. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents. Diabetes 46: 1001-1009, 1997
25. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance. Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Medicine 11: 286-292, 1994
26. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Daily G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 273: 1855-1861, 1995
27. Pimenta W, Mitrakou A, Jensen T, Yki-Järvinen H, Daily G, Gerich J: Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabetic Medicine 13: S33-S36, 1996
28. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue W, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 77 (1): 98-105, 1986
29. Polonsky KS, Given BD, Hirsch L: Quantitative study of insulin secretion and clearance in normal and obese subjects. J. Clin. Invest. 81: 435-441, 1988
30. Polonsky KS, Sturis J, Graeme IB: Non-Insulin-Dependent diabetes mellitus- a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 12: 777-783, 1996
31. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI: Decreased muscle glucose transport/ phosphorylation is an early defect in the pathogenesis of non insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 92 (4): 983-987, 1995
32. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal-weight individual revisited. Diabetes 47: 699-711, 1998
33. Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KGMM, Walker M: Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 18: 1020-1021, 1995
34. The expert committe on the diagnosis and classification of diabetes mellitus: Report of the expert committe on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197, 1997
35. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M and Laasko M: Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. J. Clin. Invest. 101: 86-96, 1998
36. Yki-Järvinnen H: Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388, 1995